Pneumocystis Jirovecii Pneumonia in Systemic Autoimmune Inflammatory Diseases

被引：0
|
作者：
Raheel, Shafay [1 ]
Matteson, Eric L. [1 ]
Crowson, Cynthia S. [2 ]
Limper, Andrew [3 ]
Porquera, Eva M. Carmona [3 ]
Specks, Ulrich [4 ]
Baqir, Misbah [5 ]
机构：
[1] Mayo Clin, Rheumatol, Rochester, MN USA
[2] Mayo Clin, Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Pulm & Crit Care Med, Rochester, MN USA
[4] Mayo Clin, Rochester, MN USA
[5] Mayo Clin, Pulm Crit Care, Rochester, MN USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1177
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases
    Braga, Beatriz P.
    Prieto-Gonzalez, Sergio
    Hernandez-Rodriguez, Jose
    [J]. MEDICINA CLINICA, 2019, 152 (12): : 502 - 507
  • [2] Pneumocystis jirovecii pneumonia in patients with autoimmune diseases
    Blaas, S.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (09): : 761 - 766
  • [3] Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases
    Ghembaza, Amine
    Vautier, Mathieu
    Cacoub, Patrice
    Pourcher, Valerie
    Saadoun, David
    [J]. CHEST, 2020, 158 (06) : 2323 - 2332
  • [4] PNEUMOCYSTIS JIROVECII INFECTION IN AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASES IN OXFORD
    Verdiyeva, Ayna
    Siosi, Alexa Escudero
    Andersson, Monique
    Woodrow, Charles
    Dubey, Shirish
    [J]. RHEUMATOLOGY, 2023, 62
  • [5] Pneumocystis Jirovecii Pneumonia in Patients with Inflammatory Myopathies
    Bruggemeyer, Cody
    Shah, Sanket
    Saygin, Didem
    Putman, Mike
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 573 - 575
  • [6] Pneumocystis jirovecii pneumonia in systemic autoimmune rheumatic disease: A case-control study
    Tadros, Susan
    Teichtahl, Andrew J.
    Ciciriello, Sabina
    Wicks, Ian P.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (06) : 804 - 809
  • [7] Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
    C. A. Pereda
    M. B. Nishishinya-Aquino
    N. Brito-García
    P. Díaz del Campo Fontecha
    I. Rua-Figueroa
    [J]. Rheumatology International, 2021, 41 : 1419 - 1427
  • [8] Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases
    Kageyama, Takahiro
    Furuta, Shunsuke
    Ikeda, Kei
    Kagami, Shin-ichiro
    Kashiwakuma, Daisuke
    Sugiyama, Takao
    Umibe, Takeshi
    Watanabe, Norihiko
    Yamagata, Mieko
    Nakajima, Hiroshi
    [J]. PLOS ONE, 2019, 14 (03):
  • [9] Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study
    Hsu, Hui-Ching
    Chang, Yu-Sheng
    Hou, Tsung-Yun
    Chen, Lung-Fang
    Hu, Li-Fang
    Lin, Tzu-Min
    Chiou, Chi-Sheng
    Tsai, Kai-Len
    Lin, Sheng-Hong
    Kuo, Pei-, I
    Chen, Wei-Sheng
    Lin, Yi-Chun
    Chen, Jin-Hua
    Chang, Chi-Ching
    [J]. CLINICAL RHEUMATOLOGY, 2021, 40 (09) : 3755 - 3763
  • [10] Is cotrimoxazole prophylaxis against Pneumocystis jirovecii pneumonia needed in patients with systemic autoimmune rheumatic diseases requiring immunosuppressive therapies?
    Pereda, C. A.
    Nishishinya-Aquino, M. B.
    Brito-Garcia, N.
    Diaz del Campo Fontecha, P.
    Rua-Figueroa, I.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2021, 41 (08) : 1419 - 1427
12345